Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb patent covers new antiinflammatory agents

Feb. 14, 2005

Aventis imparts new tubulin polymerization inhibitors for cancer therapy

Feb. 14, 2005

New anticoagulant agents reported by Bristol-Myers Squibb

Feb. 14, 2005

Three series of chemokine CCR4 receptor modulators claimed by AstraZeneca

Feb. 14, 2005

Novel PARP-1 inhibitors described by Altana Pharma in recent patent

Feb. 11, 2005

Novel protein tyrosine kinase inhibitors and their use as anticancer agents

Feb. 11, 2005

Anti-CD3 monoclonal antibodies with reduced immunogenicity claimed by Alexion

Feb. 11, 2005

Abbott presents new dopamine D3 modulators for schizophrenia

Feb. 11, 2005

Novel anticoagulant agents discovered at Lilly

Feb. 11, 2005

New tyrosine kinase inhibitors identified at Boehringer Ingelheim

Feb. 11, 2005

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...